# The Study is Being Conducted to Evaluate the Efficacy and Safety of Dexmedetomidine Hydrochloride Microneedles for Preoperative Sedation in Children

> **NCT07168720** · PHASE2 · RECRUITING · sponsor: **Guangzhou Novaken Pharm Co., Ltd.** · enrollment: 64 (estimated)

## Conditions studied

- Preoperative Sedation

## Interventions

- **DRUG:** Dexmedetomidine hydrochloride Microneedles
- **DRUG:** Dexmedetomidine hydrochloride Microneedles
- **DRUG:** placebo
- **DRUG:** Dexmedetomidine hydrochloride Microneedles
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07168720
- **Lead sponsor:** Guangzhou Novaken Pharm Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-29
- **Primary completion:** 2026-03-30
- **Final completion:** 2026-04-30
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2025-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07168720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07168720, "The Study is Being Conducted to Evaluate the Efficacy and Safety of Dexmedetomidine Hydrochloride Microneedles for Preoperative Sedation in Children". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07168720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*